open access

Vol 3, No 3 (2014)
Original articles (submitted)
Published online: 2014-07-10
Get Citation

The metabolic control in type 2 diabetic patients according to Polish Diabetes Association recommendation

Anna Kudaj-Kurowska, Iga Turek, Małgorzata Józefowska, Elżbieta Przech, Katarzyna Cypryk
Diabetologia Kliniczna 2014;3(3):92-99.

open access

Vol 3, No 3 (2014)
Original articles (submitted)
Published online: 2014-07-10

Abstract

Introduction. Treatment of diabetes should be complex and individualized to prevent chronic complications. The aim of the study was to evaluation metabolic control in type 2 diabetic patients, according to Polish Diabetes Association recommendation (2013) and to identify the factors affecting the achievement of treatment goals in patients with type 2 diabetes.

Material and methods. The study group consisted of 249 consecutively presenting type 2 diabetic patients (151 female, 98 male) treated in Wojewódzki Ośrodek Diabetologii i Chorób Metabolicznych in Łódź. Metabolic control, including HbA1c and lipids profile, BMI and blood pressure was evaluated.

Results. The mean HbA1c concentration was 7.34 ± 1.25% and in 50% of patients HbA1c was ≤ 7.0%.Total cholesterol concentration < 175 mg/dl, LDL cholesterol < 100 mg/dl, and HDL > 40 mg/dl for man and HDL > 50 mg/dl for women were state respectively in 41%, 38% and 65% patients. Normal blood pressure (< 140/90 mm Hg) was observed in 53% patients; 25% patients were overweight and 68% were obese. In studied group three and four criteria were fulfilled by 10% patients, while 22% reached any of them. Women met an average of 1.38 ± 0.93 criteria, whilemen met the criteria for 1.01 ± 0.88 (p < 0.05). HbA1c concentration correlated with diabetes duration and insulin therapy (p < 0.05).

Conclusion. Metabolic control in study population isnot sufficient. Long-term diabetes, insulin therapy and male sex are risk factors for diabetes treatment failure.

Abstract

Introduction. Treatment of diabetes should be complex and individualized to prevent chronic complications. The aim of the study was to evaluation metabolic control in type 2 diabetic patients, according to Polish Diabetes Association recommendation (2013) and to identify the factors affecting the achievement of treatment goals in patients with type 2 diabetes.

Material and methods. The study group consisted of 249 consecutively presenting type 2 diabetic patients (151 female, 98 male) treated in Wojewódzki Ośrodek Diabetologii i Chorób Metabolicznych in Łódź. Metabolic control, including HbA1c and lipids profile, BMI and blood pressure was evaluated.

Results. The mean HbA1c concentration was 7.34 ± 1.25% and in 50% of patients HbA1c was ≤ 7.0%.Total cholesterol concentration < 175 mg/dl, LDL cholesterol < 100 mg/dl, and HDL > 40 mg/dl for man and HDL > 50 mg/dl for women were state respectively in 41%, 38% and 65% patients. Normal blood pressure (< 140/90 mm Hg) was observed in 53% patients; 25% patients were overweight and 68% were obese. In studied group three and four criteria were fulfilled by 10% patients, while 22% reached any of them. Women met an average of 1.38 ± 0.93 criteria, whilemen met the criteria for 1.01 ± 0.88 (p < 0.05). HbA1c concentration correlated with diabetes duration and insulin therapy (p < 0.05).

Conclusion. Metabolic control in study population isnot sufficient. Long-term diabetes, insulin therapy and male sex are risk factors for diabetes treatment failure.

Get Citation

Keywords

type 2 diabetes, Polish Diabetes Association recommendations, metabolic control, treatment goals

About this article
Title

The metabolic control in type 2 diabetic patients according to Polish Diabetes Association recommendation

Journal

Clinical Diabetology

Issue

Vol 3, No 3 (2014)

Pages

92-99

Published online

2014-07-10

Bibliographic record

Diabetologia Kliniczna 2014;3(3):92-99.

Keywords

type 2 diabetes
Polish Diabetes Association recommendations
metabolic control
treatment goals

Authors

Anna Kudaj-Kurowska
Iga Turek
Małgorzata Józefowska
Elżbieta Przech
Katarzyna Cypryk

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Diabetologia Kliniczna dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl